Home » Topics » BioWorld

BioWorld
RSS

U.S. BIO PLANS FEBRUARY MEETING WITH FDA

Feb. 5, 1992

ANALYSTS QUESTION U.S. BIO STOCK TRADING

Feb. 5, 1992

U.S. BIO PLUNGES AFTER FDA REBUFF

Feb. 4, 1992

AMERICAN BIOGENETIC TO REDEEM WARRANTS

Feb. 4, 1992

AMGEN BEGINS STEM CELL FACTOR TRIALS

Feb. 4, 1992

VIMRX REVISES DOSING SCHEDULE

Feb. 4, 1992

ENZO SHAREHOLDERS TENDER DEBENTURES

Feb. 4, 1992

ATS, MEDISORB MESH TECHNOLOGIES

Feb. 4, 1992

ANALYST RAISES ESTIMATE FOR BIOMIRA

Feb. 4, 1992

CELLCOR FILES FOR 2 MILLION-SHARE IPO

Feb. 4, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...